ALDEYRA THERAPEUTICS INC (ALDX) Stock Balance Sheet
USA - NASDAQ:ALDX - US01438T1060 - Common Stock
5.07 USD
+0.04 (+0.8%)
5.07 USD
0 (0%)
| MRQ (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 17.50M | 23.73M | 128.51M | 135.20M | 100.40M | |||
| Cash Equivalents | 23.74M | 30.79M | 14.31M | 9.30M | 129.40M | |||
| Marketable Securities | 40.68M | 46.62M | 0.00 | 29.90M | 0.00 | |||
| Receivables | 193.50K | N/A | 0.00 | N/A | N/A | |||
| Other Current Assets | 2.64M | 2.92M | 4.99M | 6.70M | 3.00M | |||
| Total Current Assets | 84.56M | 104.07M | 147.81M | 181.00M | 232.80M | |||
| Non-Current Assets | ||||||||
| PPE Net | 404.70K | 267.00K | 516.60K | 300.00K | 400.00K | |||
| Other Non-Current Assets | 0.00 | 267.30K | N/A | N/A | N/A | |||
| Total Non-Current Assets | 404.70K | 534.20K | 516.60K | 300.00K | 300.00K | |||
| TOTAL ASSETS | 84.96M | 104.61M | 148.33M | 181.30M | 233.10M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 15.15M | 31.40K | 15.15M | 900.00K | 0.00 | |||
| Accrued Expenses | 6.93M | 12.39M | 5.78M | 14.30M | 10.80M | |||
| Accounts Payable | 1.46M | 180.50K | 1.34M | 100.00K | 1.00M | |||
| Other Current Liabilities | 6.00M | 6.00M | N/A | N/A | N/A | |||
| Total Current Liabilities | 29.53M | 18.60M | 22.26M | 15.40M | 11.80M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 15.00M | 0.00 | 14.90M | 15.50M | |||
| Other Non-Current Liabilities | 143.50K | 0.00 | 6.27M | 0.00 | 100.00K | |||
| Total Non-Current Liabilities | 143.50K | 15.00M | 6.27M | 14.90M | 15.60M | |||
| TOTAL LIABILITIES | 29.67M | 33.60M | 28.53M | 30.30M | 27.40M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -469.81M | -450.11M | -394.26M | -356.70M | -294.70M | |||
| Additional Paid In Capital | 525.05M | 521.02M | 514.00M | 507.80M | 500.40M | |||
| Common Shares | 60.10K | 59.70K | 59.20K | 100.00K | 100.00K | |||
| Other Shareholders' Equity | -11.00K | 37.40K | 0.00 | -100.00K | 0.00 | |||
| Shares Outstanding | 60.05M | 59.65M | 59.20M | 58.60M | 58.10M | |||
| Tangible Book Value per Share | 0.92 | 1.19 | 2.02 | 2.58 | 3.54 | |||
| Total Shareholders' Equity | 55.29M | 71.00M | 119.80M | 151.00M | 205.70M | |||
| TOTAL LIABILITIES AND EQUITY | 84.96M | 104.61M | 148.33M | 181.30M | 233.10M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | 0.21 | N/A | 0.10 | 0.08 | |||
| Current Ratio | 2.86 | 5.59 | 6.64 | 11.75 | 19.73 | |||
| Return On Assets (ROA) | -59.58% | -53.39% | -25.31% | -34.21% | -24.79% | |||
| Return On Equity (ROE) | -91.55% | -78.66% | -31.34% | -41.07% | -28.09% | |||
All data in USD , ROIC based on taxRate of 0.21